One in two people will get cancer in their lifetime, which sounds alarming, but it doesn’t mean cancer has suddenly become ...

One of the first things I noticed while working with oncology data at Mayo Clinic was how difficult it can be to answer what ...

The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...

CEO Martin Lehr said the company remains encouraged by CTIM-76’s development as a potentially best-in-class option for ...

TNGX stock surged 45% after clinical data revealed a 92% response rate in pancreatic cancer patients. Phase 3 trials expected ...

Earlier this week, the American Cancer Society (ACS) published its annual report in CA: A Cancer Journal for Clinicians. Each year, a team of doctors and researchers provides a comprehensive outlook ...

High-income countries that initiated widespread administration of the Human Papilloma Virus (HPV) vaccine in the mid-2000s ...

Verastem’s data in pancreatic cancer follows Revolution’s impressive daraxonrasib readout at ASCO 2026.

Source: Getty Images Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. These numbers are higher than estimates from 2023, ...

Public health has been waiting two decades1,2 for signs that human papillomavirus (HPV) vaccination prevents deaths, not only precancerous lesions and cancer. Studies in countries where HPV ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. This voice experience is generated by AI. Learn more. This voice ...